premargin

Element List	Explanation
Introduction	In reference to the announcement issued by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) dated 13/8/1446 AH corresponding to 12/2/2025 AD, regarding the approval of the CEO, Mr. Jerome Cabanas, of the Board of Directors’ request to extend his contract as CEO of the company for six months ending on August 31, 2025 AD. The company announces the expiration of the contract extension for Mr. Jerome Cabanas as CEO at the end of the working day on August 31, 2025. Dr. Ahmed bin Hamdan Al Jedaie, Managing Director, will continue to lead the company's executive management, as part of the company's commitment to enhancing efficiency and ensuring continuity in implementing its strategies and future objectives, in line with its aspirations for sustainable growth.
Previous Announcement	The Saudi Pharmaceutical Industries and Medical Supplies Company (SPIMACO ADDWAIEH) announces that the current CEO has agreed to the Board of Directors' request to extend his contract as CEO of the company, effective from March 1, 2025, to August 31, 2025.
Date of Previous Announcement on Saudi Exchange’s Website	2025-02-12 Corresponding to 1446-08-13
Hyperlink to the Previous Announcement on the Saudi Exchange Website	Click Here
Latest Developments Of The Announced Event	The company announces the expiration of the contract extension for Mr. Jerome Cabanas as CEO at the end of the working day on August 31, 2025. Dr. Ahmed bin Hamdan Al Jedaie, Managing Director, will continue to lead the company's executive management, as part of the company's commitment to enhancing efficiency and ensuring continuity in implementing its strategies and future objectives, in line with its aspirations for sustainable growth.
Reasons For The Delay on The Date of The Event Previously Announced	NA
The costs associated with the event, and if they have changed or not with indication of the reasons.	NA
Delay consequences on the Company’s financial results	NA
Additional Information	Dr. Ahmed Al-Jedaie was appointed as Managing Director pursuant to a decision by the Company's Board of Directors on 10/10/1446 AH (corresponding to 04/07/2025 AD). Dr. Ahmed Al-Jedaie holds a Master's degree in Business Administration and a PhD in Pharmacy, and has over 30 years of professional experience in the healthcare and pharmaceutical sectors. Throughout his career, he has held several leadership positions such as the Chairman of the Board of Directors of SPIMACO during the previous term, which ended in April 2025.

Saudi Pharmaceutical Industries and Medical Appliances Corp. Announces the Conclusion of the CEO's contract extension